EVKEEZA (EVINACUMAB) AVAILABLE IN ITALY
There is a new reality in Italy that is likely to affect all of Europe, as was the case with Lomitapide. “Evinacumab is reimbursed as an adjunct to diet and other therapies aimed at reducing low-density lipoprotein cholesterol (LDL-C) for the treatment of adult and adolescent patients aged 12 years …